1. Markedly induced asialoGM1⁺CD8⁺ T cell production and enhancement of antimetastatic activity by interferon β with folic or folinic acid

   • M. Iigo
   • Masami Moriyama
   • Hiroyuki Tsuda

   ORIGINAL ARTICLE Pages: 65 - 69

2. Role of perforin, granzymes and the proliferative state of the target cells in apoptosis and necrosis mediated by bispecific-antibody-activated cytotoxic T cells

   • C. Renner
   • Gerhard Held
   • Michael Pfreundschuh

   ORIGINAL ARTICLE Pages: 70 - 76

3. Prevention of superantigen-induced tolerance in vivo by interleukin-2 treatment

   • H. Belfrage
   • Mikael Dohlsten
   • Terje Kalland

   ORIGINAL ARTICLE Pages: 77 - 82

4. Establishment of internal-image anti-idiotype monoclonal antibodies to a human antibody to lung cancer

   • Hiroaki Saito
   • Masaru Taniguchi
   • T. Fujisawa

   ORIGINAL ARTICLE Pages: 83 - 87

5. Cellular characteristics of peripheral blood lymphocytes and tumour-infiltrating lymphocytes in patients with gynaecological tumours

   • T. Schöndorf
   • Heike Engel
   • Peter Mallmann

   ORIGINAL ARTICLE Pages: 88 - 96

6. 1α ,25-Dihydroxyvitamin D3 activates T cells of tumor bearers through protein phosphatase 2A

   • Kristina M. Wiers
   • Yvonne Lozano
   • M. R. I. Young

   ORIGINAL ARTICLE Pages: 97 - 102

7. Rapid elimination of mouse/human chimeric monoclonal antibodies in nude mice

   • Frank B. van Gog
   • Ruud H. Brakenhoff
   • G. A. M. S. van Dongen

   ORIGINAL ARTICLE Pages: 103 - 111

8. p53 serum antibodies as prognostic indicator in head and neck cancer

   • J. A. Werner
   • Stefan Gottschlich
   • Heinrich Rudert

   ORIGINAL ARTICLE Pages: 112 - 116

9. Interleukin-2 secretion by KHT sarcoma cells leads to loss of their vaccine potential

   • Shih-chung Hsu
   • Dorothy Glaves
   • A. K. Sood

   ORIGINAL ARTICLE Pages: 117 - 124